The novel therapy of this peptide represents a significant development in the care of diabetes mellitus type 2. Different to existing therapies, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide088821.free-blogz.com/89637156/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment